- Home
- IQ vs PLSE Comparison
IQ vs PLSE Comparison
Compare IQ & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IQ | PLSE |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | IQ | PLSE |
|---|---|---|
| Price | $1.23 | $21.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $2.91 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 11.2M | 259.6K |
| Earning Date | 02-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.45 | $840.00 |
| Revenue Next Year | $3.76 | $287.54 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.18 | $12.56 |
| 52 Week High | $2.76 | $26.30 |
Technical Indicators
Market Signals| Indicator | IQ | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 22.96 | 56.32 |
| Support Level | N/A | $13.75 |
| Resistance Level | $2.16 | $26.30 |
| Average True Range (ATR) | 0.06 | 1.42 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 15.63 | 70.03 |
Price Performance
Historical ComparisonAbout IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.